[GAVI] Geneva/Accra -- Gavi's Board today approved the establishment of the African Vaccine Manufacturing Accelerator (AVMA), a financing instrument that will make up to US$ 1 billion available to support sustainable vaccine manufacturing in Africa Efforts to translate pandemic learnings into concrete action further include the establishment of a US$ 500 million First Response Fund to ensure immediate financing for vaccine response in the event of a future pandemic, as well as extraordinary support for countries to close
